Clinical Trial Update: Methotrexate as Remission Maintenance Therapy After Remission-Induction With Tocilizumab and Glucocorticoids in Giant Cell Arteritis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating methotrexate as remission maintenance therapy after remission-induction with tocilizumab and glucocorticoids in giant cell art…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Giant Cell Arteritis

Drugs mentioned

• METHOTREXATE (METHOTREXATE)
• Tocilizumab (tocilizumab)

Snippet

Sponsor: University of Bonn | Conditions: Giant Cell Arteritis | Phase 2 | Status: ACTIVE_NOT_RECRUITING